Origin Asset Management LLP Catalyst Pharmaceuticals, Inc. Transaction History

Origin Asset Management LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$12.25 - $19.5 $137,849 - $219,433	-11,253 Reduced 44.16%	14,227 $264,000
Q3 2022 Nov 14, 2022	SELL	$7.06 - $15.52 $43,002 - $94,532	-6,091 Reduced 19.29%	25,480 $327,000
Q2 2022 Aug 11, 2022	SELL	$6.23 - $8.57 $66,798 - $91,887	-10,722 Reduced 25.35%	31,571 $221,000
Q1 2022 May 24, 2022	SELL	$5.31 - $8.31 $65,445 - $102,420	-12,325 Reduced 22.57%	42,293 $351,000
Q2 2021 Aug 13, 2021	BUY	$4.29 - $6.05 $234,311 - $330,438	54,618 New	54,618 $314,000

332

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.35B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Origin Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Origin Asset Management LLP with notifications on news.